Earning Analysis
Welcome to our in-depth analysis of KORU Medical Systems Inc(KRMD) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of KORU Medical Systems Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2025Q3 | 2025-11-12 | After Hours | -0.03 | 0.00 | +100.00 | 9.67M | 10.40M | +7.62 | +15.08 | +18.25 |
| FY2025Q2 | 2025-08-06 | After Hours | -0.03 | 0.01 | +133.33 | 9.46M | 10.19M | +7.78 | +18.71 | +27.30 |
| FY2025Q1 | 2025-05-07 | After Hours | -0.02 | 0.00 | +100.00 | 8.86M | 9.64M | +8.71 | +20.96 | +18.01 |
| FY2024Q4 | 2025-03-12 | After Hours | -0.03 | -0.02 | +33.33 | 8.89M | 8.84M | -0.61 | -17.68 | -10.98 |
| FY2024Q2 | 2024-08-07 | After Hours | -0.04 | -0.02 | +50.00 | 7.58M | 8.43M | +11.26 | +16.43 | +8.45 |
| FY2024Q1 | 2024-05-01 | - | -0.04 | -0.02 | +50.00 | 7.53M | 8.20M | +8.82 | +3.69 | +4.15 |
| FY2023Q4 | 2024-03-13 | - | -0.04 | -0.02 | +50.00 | 6.94M | 7.19M | +3.48 | +0.95 | -1.90 |
| FY2023Q3 | 2023-11-08 | - | -0.04 | -0.03 | +25.00 | 7.93M | 7.00M | -11.70 | -5.19 | -0.43 |
| - | 2023-05-04 | - | -0.04 | -0.05 | -25.00 | - | - | - | -0.73 | -4.89 |
| - | 2023-03-08 | - | -0.05 | -0.04 | +20.00 | - | - | - | +0.76 | -5.04 |
KRMD Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, KORU Medical Systems Inc reported performance for FY2025Q3, announced on 2025-11-12. The company achieved an EPS of 0.00, compared to analyst estimates of -0.03 by 100.00% . Revenue for the quarter reached 10.40M compared to expectations of 9.67M by 7.62% .
The stock price reacted with a 15.08% one-day change and a 18.25% five-day change following the earnings release. These movements reflect market reaction in KORU Medical Systems Inc growth trajectory and strategic initiatives.
KRMD Earnings Forecast
Looking ahead, KORU Medical Systems Inc(KRMD) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 10.50M and an EPS of -0.02.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 1.69%, while EPS estimates have been Revise Downward by -37.5%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Upward by 0.4% . These revisions correlate with a 39.90% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in KORU Medical Systems Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between KRMD's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
+1.69%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-37.5%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Upward
+0.4%
In Past 3 Month
Stock Price
Go Up
+39.90%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:40.74M
--
EPS Estimate-Annual FY 2025:-0.04
—
Stock Price5.68
KRMD Revenue and EPS Performance: A Historical Perspective
KORU Medical Systems Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-11-12,After Hours):
EPS: 0.00 (Actual) vs.-0.03 (Estimate) (100.00%)
Revenue: 10.40M (Actual) vs. 9.67M (Estimate) (7.62%)
Price Reaction: 15.08%(1-Day), 18.25%(5-Day)
FY2025Q2 (2025-08-06,After Hours):
EPS: 0.01 (Actual) vs.-0.03 (Estimate) (133.33%)
Revenue: 10.19M (Actual) vs. 9.46M (Estimate) (7.78%)
Price Reaction: 18.71%(1-Day), 27.30%(5-Day)
FY2025Q1 (2025-05-07,After Hours):
EPS: 0.00 (Actual) vs.-0.02 (Estimate) (100.00%)
Revenue: 9.64M (Actual) vs. 8.86M (Estimate) (8.71%)
Price Reaction: 20.96%(1-Day), 18.01%(5-Day)
Earnings Reaction
The chart below shows how KRMD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, KRMD sees a +3.82% change in stock price 10 days leading up to the earnings, and a +7.34% change 10 days following the report. On the earnings day itself, the stock moves by +0.00%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed 15.08% on the day following the earnings release and then changed by 53.44% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
KORU Medical Systems Inc (KRMD) Q3 2025 Earnings Call Summary
Positive
2025-11-12
The earnings call indicates strong international revenue growth and positive cash flow. Despite domestic revenue decline, the company has raised its revenue guidance and aims for 20%+ growth. The Q&A section highlights high nurse satisfaction and workflow improvements, existing reimbursement codes, and strong international expansion plans. Gross margin pressures are acknowledged but are being addressed. Overall, the optimistic guidance, international expansion, and raised revenue forecast outweigh domestic challenges, suggesting a positive stock price movement.
KORU Medical Systems Inc (KRMD) Q2 2025 Earnings Call Summary
Positive
2025-08-06
The earnings call highlighted strong growth in prefilled syringes, a strategic focus on expanding international markets, and a positive cash flow reinvestment plan. Although there were some delays and uncertainties, the company is mitigating these effectively. The Q&A section revealed optimism about future growth, particularly with new product launches and international expansion. Overall, the sentiment is positive, with potential for stock price appreciation given the strong business fundamentals and strategic initiatives.
KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Summary
Positive
2025-03-13
The earnings call reveals strong financial performance with 23% Q4 revenue growth and improved gross margins. Guidance indicates continued growth, particularly in international markets, and cash flow positivity by 2025. However, management's lack of clarity on certain projections and potential supply chain cost impacts could temper enthusiasm. Overall, the positive financial metrics and optimistic guidance, especially in novel therapies and international growth, suggest a positive stock price movement.
KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Summary
Positive
2025-03-12
The earnings call highlights strong financial performance, with significant revenue growth, improved gross margins, and a positive cash position. The guidance for 2025 indicates continued growth, particularly in international markets, and novel therapies. Despite competitive pressures and economic sensitivity, the company's strategic focus on AI-driven strategies and manufacturing efficiencies is promising. The Q&A reveals confidence in FDA approvals and market expansion, although management was vague on some specifics. Overall, the positive financial metrics and optimistic guidance suggest a positive stock price movement in the near term.
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Summary
Positive
2024-11-13
The earnings call shows strong financial performance with revenue growth, increased guidance, and improved margins. Despite inflationary pressures, the company maintains a robust cash position and plans for international expansion. The Q&A reveals confidence in product launches and partnerships. While there are concerns about delays and vague future projections, the overall sentiment is positive, particularly with the raised revenue and margin guidance. Considering these factors, the stock price is likely to see a positive movement in the short term.
KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Summary
Positive
2024-08-08
The earnings call indicates strong financial performance with a 22% net revenue increase and improved gross margins. Despite supply chain challenges, the company shows robust growth in international markets and novel therapies. Positive sentiment is reinforced by new collaborations, regulatory clearances, and an optimistic guidance. Q&A insights support this with strategic expansions and partnerships. The market may react positively due to these factors, although some caution is warranted regarding supply chain and competition pressures.
People Also Watch
FAQ
What were the key highlights of KRMD’s latest earnings report for FY2025Q3?
How did KRMD’s stock price react after the FY2025Q3 earnings release?
What are the revenue and EPS estimates for KRMD for 2025/Q4?
How does KRMD’s stock price correlate with earnings forecast revisions?
What should investors expect from KRMD’s next earnings report?